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Abstract
Background: Humans and mice with loss of function mutations in GPR54 (KISS1R) or kisspeptin do not progress
through puberty, caused by a failure to release GnRH. The transcriptional networks regulated by these proteins in
the hypothalamus have yet to be explored by genome-wide methods.
Results: We show here, using 1 million exon mouse arrays (Exon 1.0 Affymetrix) and quantitative polymerase chain
reaction (QPCR) validation to analyse microdissected hypothalamic tissue from Gpr54 and Kiss1 knockout mice, the
extent of transcriptional regulation in the hypothalamus. The sensitivity to detect important transcript differences in
microdissected RNA was confirmed by the observation of counter-regulation of Kiss1 expression in Gpr54 knockouts
and confirmed by immunohistochemistry (IHC). Since Gpr54 and Kiss1 knockout animals are effectively pre-pubertal
with low testosterone (T) levels, we also determined which of the validated transcripts were T-responsive and
which varied according to genotype alone. We observed four types of transcriptional regulation (i) genotype only
dependent regulation, (ii) T only dependent regulation, (iii) genotype and T-dependent regulation with interaction
between these variables, (iv) genotype and T-dependent regulation with no interaction between these variables.
The results implicate for the first time several transcription factors (e.g. Npas4, Esr2), proteases (Klk1b22), and the
orphan 10-transmembrane transporter TMEM144 in the biology of GPR54/kisspeptin function in the hypothalamus.
We show for the neuronal activity regulated transcription factor NPAS4, that distinct protein over-expression is seen
in the hypothalamus and hippocampus in Gpr54 knockout mice. This links for the first time the hypothalamic-
gonadal axis with this important regulator of inhibitory synapse formation. Similarly we confirm TMEM144 up-
regulation in the hypothalamus by RNA in situ hybridization and western blot.
Conclusions: Taken together, global transcriptional profiling shows that loss of GPR54 and kisspeptin are not fully
equivalent in the mouse hypothalamus.
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In 2003 it was discovered that the kisspeptin activated
GPR54 receptor is required for maturation and activity
of the hypothalamic-pituitary-gonadal axis [1,2]. It has
been established subsequently that kisspeptin (Kp) bind-
ing to GPR54 releases gonadotropin releasing hormone
(GnRH) from the hypothalamus to stimulate the pitui-
tary-gonadal axis in a multitude of species including
humans [3-15]. In mice, GnRH neurons express Gpr54
from birth and more GnRH neurons acquire expression
during pubertal development [16]. In rodents, Kp is
expressed by neurons in the arcuate nucleus (ARC) of
the hypothalamus and also in the rostral periventricular
area of the 3rd ventricle (RP3V) which includes the
anteroventral periventricular nucleus (AVPV). Rising
estrogen levels have a positive feedback effect on Kp
expression in the AVPV [17,18] to initiate the LH surge
required for ovulation in females [19-21]. Conversely,
estrogen and testosterone have a negative feedback
effect on Kp expression in the ARC that is regulated
through the estrogen receptor alpha (ERa)o rt h r o u g h
the androgen receptor (AR) respectively [17-19,21,22].
Despite the critical importance of GPR54/kisspeptin in
mammalian fertility, little is known of the upstream and
downstream gene regulatory networks for kisspeptin sig-
naling in the hypothalamus. The feedback relationships
between GPR54 and kisspeptin are incompletely under-
stood. To address the question of which genes are co-
dependent on GPR54 and kisspeptin and whether the
transcriptional networks of GPR54 deficient mice and
kisspeptin deficient mice are equivalent, we have taken
advantage of the knockout mice we generated during
the initial discovery of the GPR54-kisspeptin axis. Gpr54
and Kiss1 knockout mice model the hypogonadotropic
hypogonadism (HH) found in humans with GPR54
mutations [2,10,23]. Although the neuronal inputs and
projections of GPR54 and kisspeptin are barely
described, the hypothalamus is clearly a key site of inter-
est, since the action of kisspeptin on neurons co-expres-
sing GPR54 and GnRH are key to the function of the
axis. We therefore chose to focus on determining the
hypothalamic transcription network, initially scanning
the transcriptome with Affymetrix Exon 1.0 arrays.
These exon arrays contain probes for all of the known
and predicted gene exon sequences in the mouse gen-
ome, thus representing a near complete, transcriptome
profiling method.
Using micro-dissected hypothalamic tissues to isolate
RNA from our mutant mice, we first set out to define
the transcriptional differences between the knockout
mice. Since the GPR54-kisspeptin axis is subject to hor-
monal feedback and the knockout mice are pre-pubertal,
we also tested the hormonal dependence/independence
of each differentially expressed transcript. To avoid
v a r i a t i o ni ng e n ee x p r e s s i o nd u et of l u c t u a t i o n si nt h e
levels of circulating hormones during the female estrous
cycle, only male mice and testosterone (T) exposure
were used in this study. We utilized a study designed to
define purely T-regulated transcription, purely geno-
type-dependent transcription and transcription depen-
dent on both T and genotype, with interaction or no
interaction between these variables.
Results
Microarray identification of deregulated transcripts from
Gpr54 and Kiss1 knockout mice hypothalami
We first isolated RNA from micro-dissected hypothala-
mic tissue of knockout and wild-type mice and hybri-
dized this to Exon 1.0 arrays (methods). We compared
quantile normalized probe intensity values from Affyme-
trix whole mouse exon array chips where hybridization
was performed with wild-type (WT), Gpr54 knockout
(GKO) or Kiss1 knockout (KKO) hypothalamic RNA.
Affymetrix results were compared between genotypes,
specifically gene expression of all wild-type mice were
grouped together and compared with all knockout mice
grouped together (WT vs KO) or with Kiss1 knockout
mice alone (WT vs KKO) or Gpr54 knockout mice
alone (WT vs GKO). Additionally, Gpr54 knockout
mice were compared with Kiss1 knockout mice (GKO
vs KKO) to give a total of four groups (Figure 1). Gene
level and exon level summarization was used in the
comparisons and from each of these we selected genes
showing a p-value < 0.05 and an expression fold differ-
ence of 1.5 or greater, as candidates for further analysis
(yellow highlighted regions in the volcano plots shown
in Additional file 1).
This analysis yielded 198 unique genes, putatively
exhibiting differential transcription between wild-type
mice and/or either knockout (Figure 1). Several global
features of the transcription network were apparent in
these data. First, we analyzed the functional groupings
of genes and noted that signaling molecules and
enzymes were the two largest biochemical classes (Fig-
ure 1). Next, we examined possible network overlaps by
analyzing separately for the GKO and KKO differential
gene lists, the possible network connectivity using a
curated database of functional interactions, as previously
described (Ingenuity pathways, http://www.ingenuity.
com, methods). Interestingly both the GKO (Additional
files 2 and 3) and KKO (Additional files 3 and 4) net-
works show apparently common nodes of signaling via
HNF4a and growth factor signaling pathways, however
many differences are also seen in the putative networks,
suggesting that the effects of Kiss1 knockout may not be
fully equivalent to Gpr54 knockout. Consistent with this
notion, we noticed fewer statistically significant gene
level (2 vs 29, Additional file 5: Table S1) and exon level
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Page 2 of 17(26 vs 49) transcription differences for KKO mice com-
pared with GKO. To explore this possibility further we
decided to validate a subset of the most pronounced
array expression differences by QPCR. Genes showing
transcription differences were prioritized in the follow-
ing order: strength of expression, consistency of differ-
ences between knockouts, known or suspected roles in
hormonal regulation, and finally the availability of
quenching QPCR probes for low density 384 well QPCR
plate analysis. Within these criteria, all transcription fac-
tors, transmembrane receptors, and signaling molecules
that were available were included, resulting in a total of
72 genes (Additional file 6: Table S2, non-bolded genes).
QPCR control probe sets for 18S rRNA and Gapdh
were included in each array as loading controls and we
also selected a number of genes of interest (Additional
file 6: Table S2, bold genes) based on their known role
in gonadotropic signaling, that were not differentially
expressed by microarray analysis. Thus a total of 95
genes were re-validated by microplate QPCR analysis
(Additional file 6: Table S2).
We used a 384 well plate QPCR array to assay each
gene at least 3 times per sample (technical replicates)
and 3 biological replicates of RNA prepared from
micro-dissected hypothalamic tissue from wild-type,
GKO and KKO mice. After analysis of the count (Ct)
values by a linear mixed effects model, genes showed
statistically significant differential expression in one of
the groups, 7 of which had a fold change ≥ 1.5; two of
these were genes of interest (Esr1, Mmp2)a n do n ew a s
ac o n t r o l( Kiss1; Table 1). All genes with a statistically
significant fold change were carried forward for further
analysis.
Analysis of hormone-dependent and independent
hypothalamic gene transcription in Gpr54 and Kiss1
knockout mice
Array expression analysis of micro-dissected hypothala-
mic samples revealed significant differential transcrip-
tion between genotypes. However, since GKO and KKO
mice fail to undergo puberty an unknown number of
these transcriptional differences could be explained by
the hormonal milieu. To address this, we tested which
of these genes exhibited hormonally responsive tran-
scription, by measuring transcriptional differences in the
presence or absence of testosterone (T). WT, GKO and
KKO male mice were castrated and implanted with
either a sham silastic capsule, or a T containing capsule
(characteristics of the mice used in Additional file 7:
Table S4). After 4 weeks exposure, the mice were killed,
the hypothalamus micro-dissected, and the RNA
extracted. To confirm exposure to T, we measured
plasma free testosterone; KKO mean free testosterone
4.0 pg/ml (SD ± 1.5), GKO mean free testosterone 5.8
pg/ml (SD ± 2.7), and WT mean testosterone 5.3 pg/ml
(SD ± 1.5) with zero free testosterone in the castrate/
empty silastic implant group. Each gene was assayed
with at least 4 technical replicates and 3 biological repli-
cates. To reduce the risk of loss of data due to genotype
Table 1 Discovery set genes showing QPCR validated
transcriptional differences between WT and KO (Gpr54 or
Kiss1)
GKO vs WT KKO vs WT
Gene
Target
FC (95%CI) Direction FC (95%CI) Direction
Abca8a 1.85 (1.33-2.59) Up 1.97 (1.33-2.90) Up
Esr1 1.62 (1.37-1.92) Up 1.54 (1.32-1.78) Up
Kiss1 14.03 (10.86-18.11) Up N.A. N.A.
Mmp2 1.51 (1.18-1.94) Up n.s. n.s.
Npas4 2.60 (2.09-3.25) Up n.s. n.s.
Lrdd n.s. n.s. 1.80 (1.29-2.51) Up
Tmem144 n.s. n.s. 2.61 (2.21-3.08) Up
FC = fold change, CI = confidence interval, n.s. = not significant, N.A. = not
applicable. GKO = GPR54 knockout, KKO = Kisspeptin knockout.
Figure 1 Classification of 198 differentially expressed genes in
the discovery set. The figure shows the number of significant
genes identified at each step of the microarray analysis procedure
with subsequent filtering steps for statistical significance and fold
change expression differences. WT vs KO represents a joint
comparison of all data, whereas WT vs GKO and KKO represent
separated analyses. The numbers of genes falling through the
analysis are shown separately for gene level and exon level
summarization. The pie chart shows the grouping of molecular
functions for the 198 gene set.
Prentice et al. BMC Genomics 2011, 12:209
http://www.biomedcentral.com/1471-2164/12/209
Page 3 of 17or hormonal effect on loading controls, we used two
independent loading controls, 18S rRNA and Gapdh.
The data were analyzed separately using a linear mixed
effects model (methods). We analyzed GKO and KKO
mice separately in a 2 × 2 × 2 design, considering gene
(test, loading control), treatment (T+, T-) and genotype
(WT, GKO or KKO) as categorical variables. Tables 2,
3, 4, and 5 summarize the statistically significant (p <
0.05), greater than 1.5 fold expression difference, model
results for four classes of variation: (i) purely hormone-
dependent transcription (ii) purely genotype-dependent
transcription (iii) hormone and genotype-dependent
transcription but with no interaction between these vari-
ables and (iv) hormone and genotype-dependent tran-
scription, with co-dependence (interaction) between
these variables. Since two loading controls were used,
these are also reported separately as they were treated
independently in the analysis. Small differences with
loading controls were noted, resulting in differences of
interaction between genotype and hormone responsive-
ness for a few transcripts at statistical boundaries of sig-
nificance. Nevertheless, the direction and magnitude of
effects were consistent for all genes, with both control
probes. We noted fewer statistically significant transcript
regulation effects in the KKO mice, mirroring the initial
observations from microarrays. Nevertheless, several
genes (eg Klk1b22, Gnrhr, Tmem144) were regulated in
common with GKO mice, albeit with effects of different
magnitude. Several of the statistically significant QPCR
results are of small absolute magnitude and considering
the variances of the loading controls between genotypes
and treatments, we suggest that interpretation of differ-
ences of less than 1.5 fold may not be meaningful (full
tables in Additional file 8). We further considered only
changes of > 1.5 fold.
The greatest transcript level regulation was observed for
Kiss1 (Tables 1, 4), measured in GKO mice which
showed strong hormonal regulation (approximately 12
fold down-regulated with T) and moderate genotype
dependence (approximately 2 fold up-regulated in the
GKO animals). With the 18S rRNA loading control, the
regulation shows a weak interaction whereas with the
Gapdh loading control, hormonal regulation, and geno-
type regulation vary symmetrically and thus no interac-
tion is reported. The hormonal effect of Kiss1
expression in the male mouse has already been shown
[22], here, we validated the Kiss1 up-regulation in hor-
monally untreated intact male GKO mice by IHC using
a kisspeptin antibody that has been previously charac-
terised by our group and others [20]. Kisspeptin immu-
noreactivity was examined in coronal sections of the
regions containing the anteroventral periventricular
nucleus (AVPV) and the arcuate nucleus (ARC) from
f o u rW Ta n df o u rG K Oa d u l tm a l em i c e( F i g u r e2 ) .I n
terms of kisspeptin fiber distribution, fibers were found
in large numbers in the ARC in both WT and GKO
mice, and with virtually no cell bodies observed in the
AVPV region. Kisspeptin neuron cell bodies, observed
by an intense staining in the dorsal part of the ARC, are
significantly more abundant in the GKO ARC than the
WT ARC (p < 0.01). Kisspeptin fibers have a similar
intensity between the two groups. Although kisspeptin
immunoreactivity is modest in the AVPV region, we
found more kisspeptin fibers in GKO than WT in this
region (p < 0.05).
The second largest effects were found for the Klk1b22
gene (also known as b-NGF-endopeptidase) showing a
significant hormonal influence (Tables 2, 5) and 3-4 fold
regulation. As expected, the GnRH receptor (Gnrhr)
also exhibited strong hormonal regulation and a weak
genotype effect but with some interaction (the hormone
effect is relatively stronger in the KO than the WT
mice, compatible with a priming effect), however with
large variances of expression.
In KKO mice, only Gnrhr s h o w e dap u r eh o r m o n a l
regulation of its transcript and only Tmem144 showed a
purely genotype-dependent regulation. The latter was
consistent in direction and magnitude with the levels
measured in the non-castrate group of animals used for
discovery (Table 1), emphasizing this to be a robust dif-
ference. Among the genotype and hormone variant
changes, Klk1b22 showed the greatest differences, more
than 4 fold, with testosterone exposure and this effect
was significantly greater (p < 0.05) in the knockout mice
(both alleles) than wild-type.
In GKO mice, Klk1b22 showed a hormone only effect
(down-regulation) with the Gapdh control, but a
Table 2 Pure hormonal (T) responsive genes
Hormonal Effect
Genotype Gene Target FC (95%CI) Direction p-value
GKO Abca8a 1.57(1.33-1.87) Down 2.83E-05
GKO Klk1b22 2.16(1.43-3.25) Down 0.0042
KKO Gnrhr 2.33(1.63-3.33) Down 0.0009
FC = fold change, CI = confidence interval, Dir = direction of change, relative
to T. GKO = GPR54 knockout, KKO = Kisspeptin knockout.
Table 3 Pure genotype effect genes
Genotype Effect
Genotype Gene Target FC (95%CI) Direction p-value
GKO Esr2 1.63(1.46-1.82) Down 4.10E-10
GKO Hhip 1.63(1.46-1.82) Down 4.68E-10
GKO Lhcgr 1.61(1.30-1.99) Down 0.0042
GKO Npas4 1.65(1.45-1.87) Down 2.06E-08
KKO Tmem144 1.50(1.30-1.73) Up 6.12E-06
FC = fold change, CI = confidence interval, Dir = direction of change, relative
to WT, GKO = GPR54 knockout, KKO = Kisspeptin knockout.
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rRNA loading control. Gnrhr shows a strong hormonal
effect with a genotype interaction - down-regulation in
t h ew i l d - t y p em i c ea n du p - r e g u l a t i o ni nt h ek n o c k o u t
mice in the presence of testosterone. Tmem144 shows a
strong genotype effect in the GKO mice (down-regu-
lated where Kiss1 is overexpressed), but in the opposite
direction to KKO mice (up-regulated in the absence of
Kiss1), and with an additional marginal hormone effect.
We confirmed that Tmem144 is significantly up-regu-
lated in the KKO hypothalamus of the intact male
mouse as compared to WT by RNA in situ hybridiza-
tion (p < 0.001, Additional file 9). Both KKO and WT
antisense probes had significantly more intense staining
as compared to their respective sense probe control (p <
0.001), and there was not a significant difference
between the two control sense probes (p = 0.632).
To determine whether the up-regulation of the
Tmem144 gene expression in KKO mice observed by
RT-PCR and in situ hybridization existed at the protein
level, we performed a series of western blot experiments
(Additional file 10). Hypothalami dissected from WT
and KKO intact male mice were separated into the ante-
rior and posterior halves. Immunoblot analysis with an
anti-TMEM144 antibody revealed a band at the
expected size of 39 kDa, and other non-specific bands at
various sizes. Quantification of TMEM144 protein levels
(band at 39 kDa), by normalizing with b-tubulin protein
levels, showed significantly higher TMEM144 protein
levels in KKO anterior hypothalamus compared to WT
(p = 0.034, Student’s t-test). In the posterior hypothala-
mus, TMEM144 protein levels were higher in KKO than
WT, although not significantly (p = 0.131).
Genotype only effects were seen in GKO mice at > 1.5
fold but less than 2 fold for ERb (Esr2), Hhip, Lhcgr,
and Npas4. We also noticed several matrix metallopro-
teinase (MMP) family members (Mmp2, Mmp9,
Mmp28) showing mixed hormonal and genotype effects,
Table 4 Genes showing hormonal and genotype transcriptional differences, but without co-dependence
Genotype Effect Hormonal Effect
Genotype Gene Target FC (95%CI) Direction FC (95%CI) Direction p-value
GKO Abca8a 1.35(1.15-1.58) Down 1.58(1.35-1.85) Down 1.39E-07
GKO Ddx3y 1.52(1.31-1.77) Down 1.21(1.04-1.40) Down 1.52E-05
GKO Kiss1 1.96(1.64-2.35) Up 12.15(10.15-14.55) Down 4.29E-46
GKO Tmem144 1.86(1.60-2.16) Down 1.28(1.10-1.48) Down 1.51E-10
KKO Abca8a 1.21(1.06-1.37) Up 1.64(1.45-1.86) Down 1.75E-09
FC = fold change, CI = confidence interval, Dir = direction of change relative to WT (genotype panel) and T (hormone panel). GKO = GPR54 knockout, KKO =
Kisspeptin knockout
Table 5 Genes showing hormonal and genotype transcriptional differences, with co-dependence
Genotype Effect within Hormonal Group Hormonal Effect within Genotype
No testosterone Testosterone Wild-type Knockout
Genotype Gene FC (95%CI) Dir FC (95%CI) Dir FC (95%CI) Dir FC (95%CI) Dir p-value
GKO Acsm3 1.26(1.01-1.57) Up 2.28(1.84-2.83) Down 1.93(1.54-2.42) Up 1.49(1.21-1.84) Down 2.02E-08
GKO Ar 1.23(1.09-1.38) Down 1.56(1.39-1.75) Down 1.13(1.01-1.27) Up 1.12(1.00-1.25) Down 1.02E-08
GKO Esr1 1.08(0.96-1.21) Down 1.31(1.17-1.47) Down 1.28(1.14-1.43) Down 1.55(1.39-1.74) Down 1.36E-11
GKO Gnrhr 1.28(0.78-2.12) Down 3.20(1.70-6.03) Up 2.29(1.37-3.82) Down 1.80(0.96-3.35) Up 1.80E-03
GKO Kiss1 1.95(1.58-2.42) Up 1.09(0.88-1.35) Up 9.12(7.36-11.29) Down 16.34(13.19-20.23) Down 5.71E-52
GKO Klk1b22 1.25(0.71-2.20) Up 2.70(1.61-4.52) Down 1.08(0.61-1.91) Down 3.65(2.17-6.12) Down 0.0004
GKO Mmp9 1.11(0.91-1.35) Up 1.70(1.40-2.07) Up 1.11(0.92-1.35) Up 1.71(1.41-2.08) Up 2.69E-07
GKO Six2 1.05(0.73-1.50) Down 2.22(1.55-3.18) Up 1.78(1.24-2.55) Down 1.30(0.91-1.87) Up 0.0022
GKO Tec 2.48(1.95-3.14) Down 1.75(1.38-2.22) Down 1.63(1.29-2.07) Down 1.16(0.91-1.46) Down 2.03E-13
GKO Txnip 1.04(0.80-1.34) Down 1.81(1.40-2.35) Up 1.85(1.43-2.39) Down 1.02(0.79-1.32) Up 8.79E-05
KKO Acsm3 1.23(1.03-1.48) Up 1.27(1.03-1.56) Down 1.86(1.53-2.26) Up 1.19(0.98-1.45) Up 9.80E-06
KKO Klk1b22 1.30(0.92-1.84) Down 4.30(3.01-6.15) Down 1.34(0.97-1.84) Down 4.43(3.01-6.51) Down 1.75E-09
KKO Mmp9 1.03(0.68-1.56) Down 3.75(2.44-5.75) Down 1.08(0.74-1.59) Down 3.93(2.48-6.22) Down 0.0127
KKO Six2 1.08(0.84-1.40) Up 1.99(1.54-2.57) Up 1.60(1.24-2.07) Down 1.15(0.89-1.49) Up 1.14E-05
KKO Tec 1.07(0.86-1.32) Down 1.72(1.39-2.12) Up 1.63(1.32-2.02) Down 1.12(0.91-1.38) Up 1.82E-05
KKO Txnip 1.16(1.00-1.34) Down 1.22(1.06-1.41) Up 1.66(1.44-1.92) Down 1.18(1.02-1.36) Down 3.01E-08
FC = fold change, CI = confidence interval, Dir = Direction relative to WT (genotype subpanel) or T (hormone subpanel). GKO = GPR54 knockout, KKO =
Kisspeptin knockout.
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Page 5 of 17Figure 2 Kisspeptin immunostaining in WT and GKO mice brains. (A) Representative photomicrograph of immunocytochemical staining for
kisspeptin (red) in coronal brain sections of the arcuate nucleus (ARC) from wild type (WT) and Gpr54 knockout (GKO) adult male mice.
Bargraphs represent the fiber density in the dorsal ARC (a); the cell body density (b); and the ratio of cell body intensity/fiber intensity (c = b/a).
Note the significantly higher cell body/fiber ratio in the GKO brain. (B) Immunocytochemical staining for kisspeptin (red) in coronal brain sections
of the anteroventral periventricular nucleus (AVPV). Arrows indicate kisspeptin-positive fibers in the AVPV and in the medial preoptic area (MPA).
The bargraph at the bottom represents density of fibers calculated in the AVPV. * p < 0.05, * p < 0.01, unpaired t-test. 3 V: third ventricle. Scale
bar: 200 μm.
Prentice et al. BMC Genomics 2011, 12:209
http://www.biomedcentral.com/1471-2164/12/209
Page 6 of 17but for Mmp2 at a fold change less than 1.5. Mmp2 was
down-regulated by 1.4 fold in the GKO mice compared
to WT and had an independent hormonal effect shown
by a 1.2 fold decrease in gene expression when testoster-
one treatment was compared to the empty silastic con-
trol. Mmp28 had a genotype only effect in the GKO
mice and was down-regulated by 1.5 fold when com-
pared to WT (Additional file 8: Table S10). We did not
analyze in a joint statistical comparison the GKO and
KKO transcript variations from the discovery experi-
ment with the GKO T- and KKO T- animals of the vali-
dation experiment, because they are not biologically
equivalent (see discussion), since the immature testis
may be a source of feedback regulation to the
hypothalamus.
Npas4, which has very recently been described [24] as
an important activity-dependent transcription factor reg-
ulating inhibitory synapse formation in the GABAergic
system, was up-regulated in GKO mice and was the
only novel transcript for which IHC grade antibodies
were readily available (generous gift of Michael Green-
berg). The NPAS4 protein was expressed in cortical cell
bodies of WT (44/hpf - 40× high power field) and GKO
(26/hpf) mice (Figure 3C,D). NPAS4 immunoreactivity
(ir) was also seen in the hippocampus (6/hpf) (Figure
3A, B), posterior hypothalamus (Figure 3E,F) (11/hpf)
and periventricular hypothalamus (7/hpf) (Figure 3G) of
GKO mice whereas no NPAS4 ir was detectable in WT
for any of these regions (0/field) mice. As previously
described, we used the Gpr54 driven beta-galactosidase
activity (Figure 3, blue neuronal cell bodies) to examine
co-localisation of Gpr54 and NPAS4, however none of
the cell bodies overlapped in expression, indicating that
the alteration of Npas4 expression in GKO mice is non
cell-autonomous with respect to Gpr54.
Discussion
We have assessed gene expression variability amongst
Kiss1 and Gpr54 knockout mice (KKO, GKO) to deter-
mine potential gene candidates involved in either direct
or indirect regulation of this ligand-receptor pair. Initi-
ally an Affymetrix Exon 1.0 ST Array consisting of more
than 1 million probe sets (exons) was used to find gene
expression differences between the genotypes and litter-
mate wild-type mice. Initial array analysis indicated that
while there were many overlapping transcription differ-
ences between the alleles, some differences were noted.
Putative network analysis showed apparently common
nodes in HNF4a and some growth factor pathways,
however non-overlap was seen in other nodes. Moreover
fewer statistically significant expression differences were
noted in the Kiss1 knockout mice. We re-validated these
transcriptional differences, using QPCR with quenching
probes and using two loading control probes. This
yielded a set of 72 genes with confirmed transcriptional
differences between genotypes, which were supplemen-
ted with an additional 23 genes of interest and controls.
Since the knockout mice fail to undergo puberty, it was
necessary to separate transcripts that may be subject to
hormonal regulation, from those that are independent of
hormonal regulation. In a second series of experiments
we assessed the expression of the 72 array-derived gene
panel and 23 genes of interest, in the hypothalamus of
castrated mice, treated with or without hormonal
implants prior to gene expression comparisons between
genotypes. The comparison of T+, T-, and genotype
groups within the linear mixed effects model analysis
allowed us to observe genotype-dependent variation of
hormonal response and genotype-independent hormonal
response.
Around 500 GnRH expressing neurons are present in
the mouse hypothalamus [25,26]. Considering the
results of the testosterone/genotype experiment, the
detection of significant changes in Gnrhr and Kiss1 tran-
scripts indicates that the relevant region of the hypotha-
lamus was sampled and that the method used was
capable of picking up transcriptional differences in two
genes known to be hormonally regulated. Our data
show for the first time, counter regulation of Kiss1 tran-
scripts and protein expression in Gpr54 knockout mice.
This is consistent with previous reports showing that
upon interruption of the hypothalamic-pituitary-gonadal
axis, Kiss1 is elevated in the hypothalamus of rodents
[8,22,27], primates [28] and women [29].
It has been established that the anteroventral periven-
tricular nucleus (AVPV) and the arcuate nucleus (ARC)
are the key regions in the rodent hypothalamus involved
in Kiss1 expression [17-19,21,22,30]. We show here for
the first time that kisspeptin expression in male GKO
mice is localized to the cell bodies in the ARC and
absent in the AVPV. This is in accordance with the sex-
ual dimorphism in kisspeptin expression whereby males
have far fewer kisspeptin neurons in the AVPV region
than females [30]. Additionally, the kisspeptin neuron
cell bodies are significantly more abundant in the GKO
ARC than the WT while kisspeptin fibers have a similar
intensity between the two groups. Although kisspeptin
staining was modest in the AVPV region, we found
more kisspeptin fibers in GKO than WT. Thus, the up-
regulation in Kiss1 gene expression in the hypothalamus
observed by RT-PCR using the whole hypothalamus
actually occurs in the ARC only since there were no
more kisspeptin cell bodies observed in the AVPV from
GKO compared to WT mice.
Small differences, although statistically significant,
should be interpreted with caution and considering the
degree of variation seen with the loading control esti-
mates for the samples, we did not consider absolute
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Page 7 of 17Figure 3 Localization of NPAS4 in the brain of WT and Gpr54 -/- mice. For clarity the brain regions represented in panels A-F are shown
mapped to an equivalent coronal section of the Allen brain atlas, corresponding to coronal level 77 (http://mouse.brain-map.org). The
conceptual nuclear organization is shown in the right half of the panel, annotations are available at the brain atlas website. (A) WT mouse
hippocampus stained with NPAS4 antibody (B) Gpr54 knockout (GKO) hippocampus stained with beta gal (blue cell bodies) and NPAS4 (red-
brown). (C) WT cortex stained with NPAS4 antibody (red-brown) (D) GKO cortex stained with beta-gal (blue) for Gpr54 transcription and NPAS4
protein (red-brown) (E) WT posterior hypothalamus stained with NPAS4 antibody (red-brown) (F) GKO posterior hypothalamus stained with beta
gal (blue) for Gpr54 transcription and NPAS4 protein (red-brown). (G) a more anterior coronal section (level 71, map not shown here) in GKO
showing GPR54 transcription (blue, beta gal) and NPAS4 immunoreactivity in the periventricular hypothalamus. No endogenous beta-gal activity
was seen in the wild-type mice in any of the brain regions. MT: mammilothalamic tract. 3 V: third ventricle.
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statistically significant. It should also be noted that espe-
cially where interaction effects are seen, genotype and
hormone interaction effects may depend upon differ-
ences in the hormonal milieu prior to castration, that
may have occurred during development and this limita-
tion should be recognized in generalizing the results.
For example, regulation of GnRH receptor levels may
show a “priming” effect in wild-type castrate mice from
prior perinatal sex steroid exposure, compared with
knockouts. The reversed direction of hormonal effect
for Gnrhr between GKO and WT is consistent with
such an explanation [31]. As we were able to observe
robust regulation of Gnrhr, which is predominantly
restricted to the 500 or so GnRH expressing neurons in
the mouse hypothalamus, this suggests that the study
was powered sufficiently to reveal significant commonal-
ities and differences in the transcriptional networks of
Gpr54 and Kiss1 knockout mice.
Interestingly, relatively few large differences in tran-
scription were seen in the initial Affymetrix array
experiment, and overall, fewer changes were seen in the
Kiss1 knockout mice, than in the Gpr54 knockout mice.
The subsequent detailed QPCR analysis showed this
result to be reproducible. Although both genotypes fail
to undergo puberty, it has been reported that the kis-
speptin loss of function alleles may be less severe than
the Gpr54 knockout mice [32]. The endogenous basal
activity of the GPR54 receptor could explain such a dif-
ference [33] as could the existence of an unknown
weaker binding peptide ligand for GPR54. This result is
of importance for future studies directed at understand-
ing the signaling consequences of GPR54 and kisspeptin
activity.
We did not compare directly the control group of cas-
trate -T mice with the intact knockout mice. Although
the intact knockout mice are also sexually immature,
the intact immature testis may still have active feedback
to the hypothalamus and transcription differences would
be expected. Indeed, a greater difference in Kiss1 expres-
sion was seen in the intact GKO mice than the castrate
GKO mice. This is consistent with reports showing that
Kiss1 expression is up-regulated in the hypothalamus of
castrated rodents [12,22]. We also noticed opposite
direction of regulation for the genotype-only transcripts
(i.e. for transcripts where T exposure had no effect)
Npas4 and Abca8a between the first and second groups.
The proteolytic pre-processing enzymes responsible
for generating active kisspeptins in the hypothalamus
are unknown. It has been shown that Kp can down-reg-
ulate MMP9 expression [34]. We observed that Mmp9
is up-regulated when there is Kiss1 loss in the KKO
mice and the expected down-regulation is observed
when there is gain of Kiss1 expression, as we see in the
GKO mice, however these observations are specific to
the hormonally treated group for both mutants. Simi-
larly MMP2 has been shown to be down-regulated by
Kp [35] and in our study Mmp2 is down-regulated in
the highly expressing Kiss1 GKO mice, although at a
fold change less than 1.5. Additionally, reciprocal up-
regulation is absent in the KKO mice. Although it has
been demonstrated that MMP9/2 can cleave and inacti-
vate Kp, the precise relationship between the MMPs
and Kp remains to be elucidated. Mmp28 exhibited a
1.5 fold genotype only regulation, suggesting it as
another potential regulator of kisspeptin. Although all
the MMPs were consistent in showing statistically sig-
nificant transcription changes in our analysis, the extent
of regulation was less than 1.5 fold for Mmp2 and
hence these results should be interpreted with caution.
Beyond the matrix metalloproteases, we observed
Klk1b22 to be strongly regulated in the KKO and GKO
mice. Klk1b22,a l s ok n o w na sb-nerve growth factor
(NGF)-endopeptidase [36] is a member of the kallikrein
gene cluster that has been expanded by tandem gene
duplication. The predicted activity pattern for Klk1b22
is cleavage at Arg-Ser residues, an arrangement found
within mouse pre-pro kisspeptin that would result in a
52 amino acid peptide, similar to the Kp54 seen in
humans. However, Klk1b22 does not have an ortholog
in the human genome, although several very close para-
logs exist in the duplicated kallikreins. The peptide clea-
vage sequence is not conserved in the human pre-pro
kisspeptin, rather, the bond that is cleaved in the human
sequence is Arg-Gly to create the N-terminus of Kp-54
[37,38]. Our data nevertheless suggest that this kallikrein
family of peptidases is worthy of future exploration as
kisspeptin processing enzymes, especially since we show
strong evidence of regulation in response to sex steroids.
Tmem144 was the only transcript that was consis-
tently up-regulated in the KKO mice as compared with
WT mice, independent of testosterone exposure and in
all groups of KKO mice. We confirmed this up-regula-
tion by RNA in situ hybridization and western blot ana-
lysis of TMEM144 in the hypothalamus of KKO mice as
compared to WT mice. Tmem144 encodes an orphan
10-transmembrane family receptor, whose solutes and
activities are unknown. This class of transmembrane
proteins can transport a wide variety of molecules, ran-
ging from sugars and amino acids to solutes and are
generally linked to Ca
2+ mediated activation of gene
expression. Activation of non-selective cation channels
and inhibition of inwardly rectifying potassium channels
have been shown to be necessary for Kp to depolarize
GnRH neurons [39,40]. It is possible that TMEM144 is
somehow implicated in the regulation of kisspeptin
expression, its expression was high in the KKO mice
lacking Kiss1 transcripts and low in the GKO mice
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indirect negative regulator of kisspeptin. Future genetic
studies of Tmem144 will be required to evaluate this
possibility.
The transcription factor gene Npas4 was up-regulated
in the GKO mice with one of the largest fold changes
after the Kiss1 transcripts yet was down-regulated by 1.7
fold in castrated mice independent of hormonal feed-
back. This up-regulation in non-castrated mice was con-
firmed by IHC showing expression of Npas4 in the
hypothalamus of Gpr54-/- mice while Npas4 expression
w a sm o s t l ya b s e n ti nt h ew i l d - t y p em i c e .Npas4 has
been credited with regulating the development of inhibi-
tory synapses in activating neurons in the hippocampus
[24]. Interestingly, Npas4 is activated by an influx of cal-
cium [24] and is independent of the MAP kinase path-
way [41]. It has been recently reported that Kp-GPR54
signaling in the hypothalamus of rats is also indepen-
dent of the MAP kinase pathway but can signal with
calcium release [39]. Whether the Npas4 regulation is
direct or an indirect consequence of sexual immaturity,
remains to be seen, but its role in calcium dependent
activation taken together with our data suggest it may
play a role in the gonadotropic axis.
Estrogen receptor alpha (Esr1) expression was higher
in both GKO and KKO mice compared to sexually
mature wild-type males which probably reflects the
absence of negative feedback by testosterone in the
mutant mice. Consistent with this, Esr1 expression was
decreased by 1.2 fold in the castrated KKO mice that
were give testosterone implants. In contrast, expression
of the estrogen receptor beta (Esr2)w a s1 . 6f o l dl o w e r
in the GKO mice independent of testosterone effects.
Esr2 function in the hypothalamic-pituitary-gonadal axis
is currently unknown as hormonal feedback occurs
almost entirely through the estrogen receptor alpha
[17,19,22] as supported in our study. This is the first
report that Esr2 may be regulated by Kp and GPR54.
Previous studies have identified genes that show an up-
regulation in the hypothalamus during mammalian pub-
erty including Eap1 (enhanced at puberty 1) [42], Oct2
[43] and Ttf1 (thyroid transcription factor 1) [44]. The
role of these genes as key regulators of pubertal initiation
is not clear however. Disruption of expression of these
genes in the hypothalamus delays but does not prevent
entry into puberty in contrast to loss of Kp/Gpr54 signal-
ing which is associated with complete loss of puberty.
We did not observe any difference in expression of these
genes in our analysis suggesting that they may only facili-
tate puberty rather than act as essential regulators.
Conclusions
Taken together our results reveal for the first time,
using a genome-wide discovery approach, the complex
network of gene regulation that is dependent on GPR54
and kisspeptin. We have identified from this network,
transcripts whose regulation is strongly dependent on
sex-steroid exposure and therefore likely to be a second-
ary consequence of sexual immaturity in these mutants.
Importantly, we have also identified novel transcripts,
such as Tmem144 whose regulation is independent of
sex steroid exposure and are therefore prime candidates
for direct involvement in the biology of kisspeptin and
GPR54 regulation. Future genetic and biochemical stu-
dies will determine the role of these genes in the gona-
dotropic axis.
Methods
Experimental design
Part i) To discover novel gene candidates that may be
involved in the Kp-GPR54 signaling pathway, we
assessed gene expression differences in the hypothala-
mus of Kiss1 and Gpr54 knockout mice (KKO, GKO)
compared to wild-type mice (WT). Affymetrix Exon 1.0
ST Arrays sampling approximately 1 million exons, were
used to assess gene expression initially. After analysis of
t h ee x o na r r a yp r o b e s e t s ,d i f ferentially expressed tran-
scripts were re-validated using QPCR with 384-well low
density array (LDA) plates, assayed in an ABI 7900HT
real-time PCR device.
Part ii) To account for hormonally regulated tran-
scripts that may be differentially regulated as a conse-
quence of sexual immaturity in the mutant mice yet not
directly affected by Kp/GPR54 signaling, a hormonally
controlled group of mice were assessed. To ensure equal
hormone exposure in all genotypes (GKO, KKO, WT),
all mice were castrated prior to treatment. Treatment
consisted of either a testosterone implant or an empty
silastic control. The hypothalamus was again isolated for
assessment of differential gene expression, this time
using a smaller QPCR array of 48 genes.
Animals
Gpr54 and Kiss1 knockout mice have been previously
described [2,10,23]. Male 129S6/Sv/Ev wildtype, 129S6/
Sv/Ev Gpr54- or 129S6/Sv/Ev Kiss1- knockout mice
were housed under conditions of 12 hours of light with
ad libitum access to food and water. The average age of
the mice from the first analysis was 60-70 days and 90
days for the second hormonally controlled group. All
experimental protocols were performed under the
authority of a United Kingdom Home Office Project
License and were approved by the Cambridge Animal
Ethics Committee.
Castration and testosterone implants
Adult males were bilaterally castrated under general
anaesthesia using Ketamin/Xylasine. Castrated mice
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empty implant or bilateral castration plus testosterone
implant. Testosterone implants were manually and asep-
tically prepared in the laboratory using silicone tubing
(0.058 inch ID/0.077 inch OD; Dow Corning) filled with
crystalline testosterone (T-1500; Sigma Aldrich, UK),
and sealed with adhesive silicone type A glue [45].
Implants were inserted subcutaneously at the time of
castration. Mice were allowed approximately 3 - 4 weeks
for recovery (the first week with paracetamol in the
water supply), and killed by CO2 exposure. Blood was
collected in a heparinized syringe from the inferior vena
cava and centrifuged at 1,000 × g for 10 min at 4°C.
T h ep l a s m as u p e r n a t a n ts a m p l e sw e r ec o l l e c t e da n d
stored at -20°C. The mice characteristics are listed in
Additional file 7: Table S4.
Testosterone assay
Free testosterone was measured in duplicate using an
ELISA kit (DB52181; IBL, Hamburg, Germany) with a
sensitivity of 0.17 pg/ml and intra- and inter-assay varia-
tion coefficients respectively 8.9% and 8.8% [23].
Hypothalamus dissection for RNA extraction
After removal of the brain, the meninges and optic
chiasm were discarded and the hypothalamus was iso-
lated. The external limits for this dissection were: lateral,
the external border of the medial preoptic area and
more caudally, the lateral borders of the mammillary
nucleus; dorsal, 1.5 mm depth; anterior, the anterior
limit of the nucleus of the vertical limb of the diagonal
band (bregma + 1.34 mm); and posterior, the posterior
limit of the mammillary nucleus (bregma - 3.40 mm).
The whole hypothalamus contained at least the follow-
ing main hypothalamic nuclei: arcuate nucleus (ARC),
anteroventral periventricular nucleus (AVPV), antero-
dorsal preoptic nucleus (ADP), magnocellular nucleus
(MA), supraoptic (SON) and paraventricular (PVN)
nuclei, medial preoptic area (MPO) and the diagonal
band of Broca (DBB). Immediately after dissection,
hypothalami samples were placed in 600 μlo fR N A l a t e r
(Applied Biosystems, UK) and kept at 4°C for 24 h and
then stored at -20°C until RNA extraction.
RNA extraction
RNA was extracted using the Qiazol method (Invitro-
gen, Carlsbad, CA) that is recommended for fatty tis-
sues. Whole hypothalami were removed from RNAlater,
with excess reagent blotted off of the tissue with a kim-
wipe before being placed in 100-200 μlo fQ i a z o l .T h e
hypothalami were then homogenized using a Kontes
Pellet Pestle (Fischer Scientific, Ottawa, ON) hand-held
homogenizer until a uniform mixture was achieved. The
remaining Qiazol up to 1 ml was added to the
homogenized mixture and the total homogenate was
placed in a phase lock tube to separate out the aqueous
phase through centrifugation. RNA was precipitated out
of the aqueous phase with an equal volume of isopropa-
nol and pelletted by centrifugation. Seventy percent
ethanol was used to wash the pellet that was then air-
dried, resuspended into 5.5-11.5 μl of RNase/DNase free
water, and heated to 65°C for 10 min. One and a half
microliters of RNA was set aside for Agilent analysis
and RNA was stored at -80°C.
Agilent analysis
RNA concentration and integrity (RIN) were determined
by the Agilent 2100 bioanalyzer as per manufacturer’s
recommendations. Briefly, 1 μl of heat denatured RNA
mixed with 5 μl of Nano Marker was run on a RNA
6000 NanoChip (Agilent Technologies, Mississauga,
ON) already prepared with prefiltered Nano gel matrix
mixed with Nano dye concentrate. RNA samples were
compared to 1 μl of NanoChip RNA 6000 ladder.
Affymetrix procedure
Hypothalamic RNA was purified further using the Gene-
Chip Whole Transcript Sense Target Labeling Assay
(Affymetrix, Santa Clara, CA) as per manufacturer’s
recommendations before being hybridized to a Gene-
Chip Mouse Exon 1.0 ST Array (Affymetrix, Santa
Clara, CA). One microgram of RNA was used as starting
material with all samples having a RIN ranging between
8.2-9.0. Starting RNA was mixed with Control Poly-A-
RNA before using the RiboMinus Transcriptome Isola-
tion Kit (Invitrogen, Carlsbad, CA) as per Affymetrix
recommendations to reduce the rRNA contamination
within the sample. Each batch of RNA run through the
RiboMinus kit was run in parallel with mouse liver RNA
that had either been rRNA reduced or left unreduced as
a comparison for effectiveness of the RiboMinus assay.
The rRNA reduced samples and liver controls were then
purified and concentrated using the GeneChip In vitro
transcription (IVT) cRNA Cleanup Kit and assessed by
Agilent analysis. Successfully rRNA reduced samples
continued forward to first strand cDNA synthesis using
T7-(N)6 primers and SuperScript II enzyme before sec-
ond strand cDNA synthesis using DNA Polymerase I.
Within 10 min of second strand cDNA synthesis, sam-
ples were run through the GeneChip Whole Transcript
cDNA Amplification Kit before IVT cRNA Cleanup and
then assessed for cRNA concentration by NanoDrop
analysis (NanoDrop Technologies, Wilmington, DE).
Samples with cRNA concentrations equal to or greater
than 10 μg in a total volume of 6.5 μl were carried for-
ward to the second cycle of first-strand cDNA synthesis
using the GeneChip Whole Transcript cDNA synthesis
Kit. Random primers with a deoxyuridine triphosphate
Prentice et al. BMC Genomics 2011, 12:209
http://www.biomedcentral.com/1471-2164/12/209
Page 11 of 17(dUTP) component mixed within the deoxynucleotide
triphosphates (dNTPs) were used. The single stranded
cDNA was then treated with RNase H to hydrolyze any
remaining cRNA and run through the cDNA Cleanup
Spin Columns as per the GeneChip Sample Cleanup
Module. Eluted cDNA was assessed by NanoDrop for
sample concentration. Finally, 5.5 μg of single stranded
cDNA was fragmented with Uracil DNA Glycosylase
(UDG) and APE 1 then labeled with biotin allonamide
triphosphate (TdT) using the GeneChip Whole Tran-
script Terminal Labeling Kit before being hybridized for
17 h to the Mouse 1.0 ST Array chip in the GeneChip
Hybridization Oven 640 using the GeneChip Hybridiza-
tion, Wash and Stain Kit. Before scanning the chip on
the GeneChip Scanner 3000 7G, each chip was run
through the GeneChip Fluidics Station 450 for washing
and staining with Streptavidin Phycoerythrin (SAPE).
When the sample yielded a concentration less than
required for subsequent steps in the protocol, the pro-
cess was started over again and resulting volumes amal-
gamated (and in some instances vacuum centrifuged to
increase the concentration) before moving forward to
the next step.
Quantitative real-time polymerase chain reaction (QPCR)
The Applied Biosystems (ABI) 7900HT Fast Real-Time
System was used to amplify and detect mouse cDNA
transcripts (Applied Biosystems, Foster City, CA). For
high throughput detection a Taqman Low Density Array
(LDA) Card from ABI consisting of 95 genes including
two endogenous control genes (Gapdh and 18S rRNA)
was custom ordered. To assess the second group of
mice independent of hormonal feedback, a second smal-
ler LDA set was ordered consisting of 48 genes. The
gene list was similar to that of the first larger LDA and
had the same two endogenous controls. The complete
list of genes used for both LDAs are in Additional files
2 and 11.
Network analysis
Analysis was conducted using literature-curated data at
http://www.ingenuity.com. A data set containing gene
identifiers from the GKO and KKO expression arrays
and corresponding expression values was uploaded into
in the application. Each identifier was mapped to its
corresponding object in Ingenuity’s Knowledge Base. All
expression values passing initial array significance analy-
sis were included and used. These molecules, called
Network Eligible molecules, were overlaid onto a global
molecular network developed from information con-
tained in Ingenuity’s Knowledge Base. Networks of Net-
work Eligible Molecules were then algorithmically
generated based on their connectivity. The top 3 canoni-
cal networks with more than 3 molecules were merged
into a global network for the GKO and KKO genes
(Additional files 2 and 4). For clarity each of the three
individual networks is also shown separately (Additional
file 3).
Kisspeptin Immunohistochemistry (IHC)
Four WT and four GKO male mice were deeply
anesthetized with pentobarbital (400 mg/kg, i.p.) and
perfused transcardially with 20 ml of 4 % paraformalde-
hyde in 0.1 M phosphate buffer (PB), pH 7.4. Brains
were removed and immersed in the same fixative for 1
h at 4°C and stored in PB until sectioned. 40 μm Vibra-
tome (VT1000S; Leica, Wetzlar, Germany) coronal float-
ing sections containing the anteroventral periventricular
(AVPV) nucleus and the arcuate nucleus (ARC) regions
were incubated for 16 h at 4°C in a polyclonal rabbit
anti-kisspeptin-10 antiserum (1:5,000; no. 566, gift from
A. Caraty, Tours, France) in Tris-buffered saline (TBS;
0.2 M Tris, 0.15 M sodium chloride) solution containing
0.3% Triton X-100, and 5% normal goat serum. Sections
were then washed four times in TBS (10 min/wash) and
exposed to Alexa Fluor 568-conjugated anti-rabbit anti-
body (1:500, Invitrogen) for 1 h at room temperature.
After washes, sections were incubated for 5 min with
DAPI 10 μg/ml (D9542, Sigma Aldrich) in TBS for
nuclear fluorescent staining, washed with TBS, mounted
on polysine glass slides and coverslipped in FluorSave
(345789, Merck).
Immunofluorescent labelling images were acquired
with a fluorescent system (Axia Imager A1 microscope,
AxioCam MRc5 camera, Axiovision software; Zeiss).
Alexa 568 positive staining was examined with the FS45
filter set (560-630 nm). For illustration purposes, photo-
montages were prepared with the help of Photoshop
Elements 4.0 and Illustrator CS3 (Adobe Systems).
Analysis was undertaken by using digital images
acquired with a 10× objective. For the kisspeptin stain-
ing analysis in the AVPV region, four images were
recorded for each animal under the exact same micro-
scope and software settings. Each image was converted
to greyscale format and both hemisections were ana-
lyzed. In each hemisection, both background (in the
medial preoptic area, distal to the third ventricle) and
AVPV intensity were considered. The staining intensity
was measured using the histogram function in Photo-
shop Elements 4.0. Specific intensity in the AVPV was
calculated by subtracting the background intensity from
the AVPV intensity and was expressed in arbitrary unit.
Staining analysis in the ARC region was performed as
for the AVPV with four images for each animal but we
differentiated the kisspeptin fibers (dorsal ARC) from
the kisspeptin cell bodies (ventral ARC). In each hemi-
section, background intensity was measured in the lower
left corner of the image to normalize the data.
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dorsal and ventral parts of the ARC respectively, were
calculated by subtracting the background intensity and
were expressed in arbitrary unit. The ratio of cell body
intensity/fiber intensity was also calculated. Values for
each mouse were used to determine mean counts, and
these were used to generate means ± SEM values for
each group. The comparison between each group was
subjected to an unpaired Student’s t-test.
Hypothalamus dissection for protein extraction
Four WT and four KKO male mice were killed by CO2
exposure. Brains were removed and the hypothalamus
was dissected in two parts: the anterior (AntH) and the
posterior hypothalamus (PostH). AntH mainly contains
the anteroventral periventricular nucleus (AVPV), the
diagonal band of Broca (DBB), the median preoptic
nucleus (MnPO), the medial preoptic area (MPA), the
medial preoptic nucleus (MPO), and the periventricular
nucleus (PeN). PostH mainly contains the arcuate
nucleus (ARC), the dorsomedial hypothalamic nucleus
(DMH), the lateral hypothalamus (LH), and the ventro-
medial hypothalamic nucleus (VMH). AntH and PostH
tissues were snap frozen in liquid nitrogen and stored at
-80°C until protein extraction. Briefly, tissue fragments
were dissociated through a 25 G needle in 300 μlo f
lysis buffer (pH 7.4, 25 mM Tris, 50 mM b-glyceropho-
sphate, 1.5 mM EGTA, 0.5 mM EDTA, 1 mM sodium
pyrophosphate, 1 mM sodium orthovanadate, Complete
protease inhibitors 1X (Roche), 100 μg/ml PMSF, and
1% Triton X-100. The tissue lysates were cleared by
centrifugation at 10,000 g for 15 min and protein con-
tents were determined using the Bradford method (Bio-
Rad). Protein concentration of each sample was adjusted
with lysis buffer and one volume of loading buffer 4X
(80 mM Tris-HCl, 4% SDS, 40% glycerol, 10% b-mer-
captoethanol, and bromophenol blue, pH 6.8) was added
to 3 volumes of protein lysate. Finally, samples were
boiled for 5 min before storage at -80°C until use.
Western blot analysis
Samples were re-boiled for 5m i na f t e rt h a w i n ga n d3 0
μg of protein per sample were electrophoresed for about
80 min at 125 V in 10% SDS-polyacrylamide gels using
a Bio-Rad Mini-Protean system. After size fractionation,
the proteins were transferred onto polyvinylidene
difluoride 0.45 μm pore-size membranes (Immobilion-P,
Millipore) using a semi-dry blotting apparatus (Atto,
Japan) for 75 min at room temperature (RT). Blots were
blocked for 1 h in TBS with 0.05% Tween 20 (TBST)
and 5% non-fat milk at RT, incubated overnight at 4°C
with a rabbit polyclonal anti-TMEM144 primary anti-
body (SAB2102456, Sigma) at 1 μg/ml dilution. After
incubation with primary antibody, membranes were
washed four times with TBST before being exposed to
HRP-conjugated secondary anti-rabbit IgG diluted in 5%
non-fat milk TBST for 1 h at RT. The immunoreactions
were revealed with enhanced chemiluminescence
(RPN2132, GE Healthcare) and detected with an X-ray
film (Konica Minolta). Membranes were then stripped
in a stripping solution (62.5 mM Tris-HCl, 2% SDS, pH
6.7, and 100 mM b-mercaptoethanol) for 30 min with
gentle rocking at 65°C. Membranes were washed and
incubated with HRP-conjugated secondary anti-rabbit
IgG antibody was used to verify that all former immu-
noreactivity was successfully stripped. Membranes were
re-probed with a mouse monoclonal anti-b-tubulin
1:10,000 under the same conditions as described above
for the anti-TMEM144 antibody and detected with a
HRP-conjugated secondary anti-mouse IgG 1:2000.
Analysis was undertaken by using digital images
acquired with a scanner Epson Perfection 1260 and pro-
cessed by Photoshop Elements 4.0. The intensity of each
band for TMEM144 and b-tubulin was measured using
the histogram function in Photoshop and the relative
content of TMEM144 was normalized by calculating the
ratio TMEM144 intensity/b-tubulin for each sample.
Values for each mouse were used to determine mean
counts, and these were used to generate means ± SEM
values for each group. The comparison between each
group was subjected to an unpaired Student’s t-test.
NPAS4 immunohistochemistry (IHC)
Mice (three of each genotype) were perfused with 4.0%
paraformaldehyde/PBS prior to brain dissection, which
were then immersed in 20% sucrose overnight. The
brains were frozen in OCT and cryosectioned at 20
microns. Sections were placed onto positively charged
slides and kept at -80°C. Slides were then hydrated with
PBS briefly prior to b-galactosidase treatment overnight
[10]. Slides were washed with PBS then incubated with
4% paraformaldehyde for 10 minutes, then washed with
PBS followed by a 0.03% hydrogen peroxide treatment
for 10 minutes. After a PBS wash slides were incubated
with serum-free protein block (Dako) for 2 hours then
incubated overnight at 4°C with 1:500 NPAS4 antibody
generously donated by Michael Greenberg’s laboratory
[24]. Secondary antibody was 1:100 Goat anti-Rabbit
HRP (Dako) for 2 hours. Reactivity was visualized using
DAB chromogenic solution, slides were mounted in 50%
PBS and 50% glycerol and coverslipped. At least two
brains were examined for each genotype studied. Micro-
scopy was conducted using a Zeiss Axioscope, with
phase contrast.
RNA in situ hybridization (ISH)
The frozen brain sections were prepared as for the
NPAS4 IHC except at a thickness of 10 microns for two
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dure was based on a protocol developed by Dijkman et
al. available through the Roche website (http://www.
roche-applied-science.com/PROD_INF/MANUALS/
InSitu/InSi_toc.htm). Specifically, slides were heated at
50°C for three minutes and allowed to air dry at RT for
30 minutes. They were then treated with chloroform for
5 minutes and allowed to dry for 5 minutes. The slides
were then treated with 4% paraformaldehyde in PBS for
7 minutes then washed in PBS, followed by washes in 2
× SSC. The prehybridization step used 100 μl of hybridi-
zation buffer (4 × SSC, 10% dextran sulfate, 1X Den-
hardt’s solution (Sigma-Aldrich) 2 mM EDTA, 50%
deionized formamide, 500 μg/ml salmon sperm DNA) at
37°C for 1 hour. The sense and antisense probes were
added to the hybridization buffer at a concentration of
200 ng/l and slides were incubated with the probes in a
humidified chamber overnight at 37°C.
The probes were created by PCR amplification using
cDNA from a WT mouse hypothalami and PCR primers
that included the Sp6 and T7 promoter sequences for
RNA transcription. The sense primer sequence was
ATT TAG GTG ACA CTA TAG ATG AGC AGC
AAT GCA ACA GAC and the antisense primer
sequence was TAA TAC GAC TCA CTA TAG GGC
GTG AGC GCA CTT ACT ACT GA. The PCR product
produced the expected single 461 bp band on gel elec-
trophoresis and was Sanger sequenced prior to gel
extraction to confirm the correct Tmem144 sequence.
The Roche Digoxigenin (DIG) RNA Labeling Kit (SP6/
T7) was used to create the DIG label sense and anti-
sense probes as per manufacturer’s recommendation.
After probe hybridization the slides were washed with
2 × SSC followed by a 60% formamide in 0.2 × SSC
wash both at 37°C. There were final washes with 2 ×
SSC at RT and with 100 mM Tris-HCl, 150 mM NaCl
(pH 7.5) prior to probe detection. The Roche DIG
Nucleic Acid Detection Kit (NBT/BCIP) was used to
visualize the ISH probes. Specifically, the sections were
incubated for 30 minutes at RT with blocking buffer
(100 mM Trish-HCl, 150 mM NaCl used to dilute 10X
blocking reagent to 1X). The alkaline phosphatase-con-
jugated sheep anti-DIG was diluted to 1:200 in the
blocking buffer and used to incubate the slides for 2
hours at RT. After incubation the slides were washed
with 100 mM Trish-HCl, 150 mM NaCl and incubated
for 10 minutes with detection buffer (100 nM Tris-HCl,
100 mM NaCl, 50 mM MgCl2). Slides were incubated
overnight with detection buffer containing 0.18 mg/ml
5-bromo-4-chloro-3-indolyl-phosphate, 0.34 mg/ml
nitroblue tetrazolium chloride (Roche kit) and 240 μg/
ml levamisole at RT. After a distilled water wash the
slides were counterstained with 1% methylene green and
mounted in aqueous based media. Microscopy was
conducted with an Olympus BX46 light microscope and
captured with the Olympus DP21 digital camera.
RNA ISH image analysis and quantification
Images of tissue sections were analyzed by our in-house
image processing package (imQui), which provided an
interactive, user-interface to test and setup the proces-
sing pipeline as well as the utility to execute the devel-
oped pipeline on the set of images. First, each color
image was separated into its red, green, and blue com-
ponents. As the red channel image contained the least
noise among the three colors, it was chosen for nuclei
segmentation and measurements. The red image was
inverted to appear like a fluorescence image, such that
previously developed nuclei segmentation algorithms
could be used [46]. Background subtraction was
employed to compensate for lighting and shading varia-
tions in the image. Otsu thresholding and watershed
segmentation were then applied to detect and separate
any touching nuclei. For each nuclear defined region,
the mean intensity of the object (in the red channel
image) was evaluated. Finally, the estimated absorbance
density for each object was evaluated by subtracting the
logarithm of the mean object intensity by the logarithm
of the illumination intensity (the same illumination
intensity level was used for all images, since the same
imaging conditions were applied to all images). Compar-
ison of significance in differences between samples was
performed using a two-sided Student’st - t e s to nt h e
optical density values.
Affymetrix and QPCR statistical analysis
(i) Affymetrix chip data was quantile normalized and
corrected using the GC-RMA algorithm [47]. Stratagene
ArrayAssist version 5.1.0 was used to analyze the Affy-
metrix data (located at: http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?token=vxytbewkkqaqeze&acc=GS
E28383) and create volcano plots. Experimental groups
were compared using unpaired t-tests. Differential
expression was analyzed with gene-level and exon level
models in ArrayAssist and genes passing the filters (Fig-
u r e1 )o f>1 . 5f o l de x p r e s s i o nd i f f e r e n c ea n dp <0 . 0 5
after correcting for multiple comparisons were included.
Using the volcano plot distributions additional outliers
(locally isolated data points, showing large fold change
or small p-value, Additional file 1) were included. Table
S1 in Additional file 5 lists the characteristics and probe
values for the 198 genes passing these criteria.
(ii) QPCR data was analyzed using linear mixed effects
models, with experimental groups compared via the
likelihood ratio chi-square statistic [48,49]. Adjustment
for multiple comparisons was performed using the Ben-
jamini-Hochberg method [50]. For the testosterone chal-
lenge experiment, a linear mixed effects model was used
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(Gapdh, 18S rRNA) and test genes.
Yijklm = μ + δi + γj + τk + δγij + δτik + γτ jk + δγτijk + αl(jk) + εm(ijkl)(1:1)
Yijklm = QPCR cycle time for gene target i, genotype j,
hormone condition k, animal l(jk) and technical repli-
cate m(ijkl) where;
i = 1 (loading control), 2 (gene of interest)
j = 1 (WT), 2 (KO)
k = 1 (No testosterone in implant), 2 (testosterone in
implant)
l = 1, 2, ..., nl(jk) indicates mouse number for condi-
tions j and k
m = 1, 2, ..., nm(ijkl) indicates technical replicate for
conditions i, j, k, l.
μ = overall Ct level
δi = change in Ct level corresponding to gene target
(loading control or gene of interest)
gj = change in Ct level due to genotype
τk = change in Ct level due to hormone implant
al(jk) = random effect on Ct level attributable to the
lth animal within conditions j and k, arising from a
Gaussian distribution with mean 0 and variance sa
εm(ijkl) = random effect on Ct level due to technical
variability, arising from a Gaussian distribution with
mean 0 and variance sε
The remaining terms δgij, δτik, δτjk and δgτijk represent
second and third order interaction terms of the three
main effects. Estimates of these parameters obtained
from the data via restricted maximum likelihood fitting
(REML) will be denoted with a circumflex, for example
the estimate of the difference in expression level due to
genotype j gj is denoted as ˆ γj.
δgij allows the model to reflect a different expression
level in the gene of interest in the KO (ΔCt in the KO)
as compared to that seen in the WT in the placebo
implanted animals (ΔCt in the WT). Thus in QPCR ter-
minology ΔΔCt for the placebo implanted animals is
estimated by
 
δγij.
δgτijk allows the model to reflect a different expression
level in the gene of interest in the KO (ΔCt in the KO)
as compared to that seen in the WT in the testosterone
implanted animals (ΔCt in the WT). In QPCR terminol-
ogy ΔΔCt for the testosterone implanted animals is esti-
mated by
 
δγij +
 
δγτijk.
δτik allows the model reflect a different baseline
expression level of the gene of interest in the testoster-
one implanted animals relative to the placebo implanted
animals.
gτjk allows the model to reflect a different baseline
expression level of the loading control in the knockout
animals relative to the wild-type animals.
In the terminology of linear mixed effects models,
gene target, genotype and hormone implant factors are
fixed effect factors; and animal is a random effects fac-
tor. Animal is modeled as a random effect as the animal
effect for each animal is not of interest in this experi-
ment. Rather, the results are to be interpreted with
respect to the overall mouse population, and the animals
included in this experiment represent a random sample
from the overall population. The two genotypes, Kiss1
knockout and Gpr54 knockout, were modeled separately
using the model (1.1). Although all factors could have
been put in one 2 × 2 × 3 model, for simplicity the data
from Kiss1 and Gpr54 knockouts were modeled sepa-
rately, in two 2 × 2 × 2 factorial designs (genotype: wt
o rk o ;t r e a t m e n t :T -o rT + ;g e n e :t e s to rl o a d i n gc o n -
trol). The relationship between the model-estimated
means for each of the conditions allowed inference of
four effect types of interest. These were: genotype only
transcription differences, hormone treatment only tran-
scription differences, hormone and genotype differences
where the rate of difference is symmetrical (no interac-
tion between effects), and hormone and genotype differ-
ences where the differences between groups show an
effect interaction (ie the difference for hormone treat-
ment is disproportionately greater in one genotype). The
linear model was fitted using the lmer function from the
lme4 package implemented in R-2.7.0 [51,52]. The
model output was used to construct estimates of the
mean relative effect and direction, 95% confidence inter-
vals, and omnibus p-value (from likelihood-ratio chi-
square test of any effect due to genotype or hormone
adjusted for multiple corrections by the Benjamini
Hochberg method).
Additional material
Additional file 1: Supplemental Figure 1. Volcano plots from the
Affymetrix Exon 1.0 ST Array. Genes that were considered for further
analysis are represented by yellow squares. The x-axis is the fold change
for comparison groups that are indicated on the left side of the figures.
The y-axis is the p-value among biological replicates.
Additional file 2: Supplemental Figure 2. GKO hypothalamic
transcription networks merged. The top three networks of GKO
hypothalamic transcription merged.
Additional file 3: Supplemental Figure 4. GKO and KKO
hypothalamic transcription networks. The top three networks for both
GKO and KKO hypothalamic transcription shown separately.
Additional file 4: Supplemental Figure 3. KKO hypothalamic
transcription networks merged. The top three networks of KKO
hypothalamic transcription merged.
Additional file 5: Supplemental Table 1. The characteristics and probe
locations of the outliers from the volcano plots representing the
Affymetrix results.
Additional file 6: Supplemental Table 2. Genes carried forward for
QPCR validation from initial array analysis. Lists the 95 genes
assessed by QPCR that were chosen from the initial array analysis.
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Page 15 of 17Additional file 7: Supplemental Table 4. Characteristics of the
hormonally treated mice. Lists the characteristics of the mice used in
the T response cohort.
Additional file 8: Supplemental Tables 5-12. These tables list the
complete model results for the four classes of variation for each
genotype: (i) purely hormone-dependent transcription (ii) purely
genotype-dependent transcription (iii) hormone and genotype-
dependent transcription but with no interaction between these variables
and (iv) hormone and genotype-dependent transcription, with co-
dependence (interaction) between these variables.
Additional file 9: Supplemental Figure 5. Tmem144 in situ
hybridization in the hypothalamus of WT and KKO male mice.
Tmem144 in situ hybridization in the ARC of the hypothalamus of WT
(top) and KKO (bottom) intact male mice (A). The sense probe is used as
a negative control and is shown on the left while the antisense probe
stains as a dark brown precipitate and is shown on the right.
Quantification of the optical density is shown in a bar graph (B) where
the asterisk denotes statistical significance between the means. *: p >
0.01. S: sense. AS: antisense. 3 V: third ventricle. Scale bar represents 100
μm.
Additional file 10: Supplemental Figure 6. TMEM144 protein
content in the hypothalamus of WT and KKO male mice.
Immunoblotting of anterior hypothalamus (A) or posterior hypothalamus
(B) protein lysates showed bands at 39 kDa for TMEM144 and 50 kDa for
b-tubulin. Bargraphs represent the TMEM144 protein levels in the
anterior (A) and the posterior hypothalamus (B), and are expressed in
arbitrary unit as the mean of the ratio Tmem144/b-tubulin in each
sample. Note the significantly higher TMEM144 protein expression in the
anterior hypothalamus from KKO mice (* p = 0.034, n = 4 for each).
Individuals are numbered 1 to 8.
Additional file 11: Supplemental Table 3. Genes carried forward
into the T response QPCR analysis. Lists the 48 genes assessed by
QPCR using the T response cohort of mice.
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